Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × bicalutamide × 30 days × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostate Adenocarcinoma 1

Interventions

Specimen Handling 86 Biopsy 67 Magnetic Resonance Spectroscopy 59 pembrolizumab 57 Cyclophosphamide 45 Nivolumab 34 venetoclax 28 fludarabine 27 Cetuximab 22 Gemcitabine 19 Radiotherapy 18 Cisplatin 18 Carboplatin 18 Ipilimumab 16 Fluorouracil 16 Bevacizumab 16 atezolizumab 15 Oxaliplatin 15 Cytarabine 15 Azacitidine 15 Paclitaxel 14 X-Rays 13 Radiosurgery 13 tislelizumab 12 fludarabine phosphate 12 Temozolomide 12 Lenalidomide 12 Dexamethasone 12 Prednisone 11 Leucovorin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04943536 2026-02-27

BiolenRT

Alessa Therapeutics Inc.

Phase 1 Active not recruiting

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡